RBM7 and breast carcinoma: The survival curve data of RBM7 from the Human Protein Atlas revealed that upregulation of RBM7 was correlated with poorer prognosis (Log-rank P-value i = 2.90e−3 < 0.05) in breast cancer patients (Fig. 1f).